New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents

A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery. Researchers hope to one day replicate the result in humans.

Read the whole article on Physorg

More from Physorg